Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Galilaeus Oy

Galilaeus is a process development and contract manufacturing company dedicated to provide innovative, efficient and proprietary manufacturing solutions for the pharmaceutical industry. Proven expertise of microbial strain improvement and fermentation development are the building blocks of our high quality products and services.


Contact Details:
Kairiskulmantie 10 P.O.BOX 113
KAARINA
FIN- 20781
Finland
Tel:358-2-2741 450
Fax:358-2-2731 460
Email:galilaeus@galilaeus.fi
WWW:

www.galilaeus.fi/




Recent Publications by Galilaeus Oy:

Expanding the scope of aromatic polyketides by combinatorial biosynthesis.
Combinatorial biosynthesis is a technology for mixing genes responsible...
3rd December, 2003
Galilaeus Oy, Kaarina, Finland. Comb Chem High Throughput Screen. 2003 Sep;6(6):501-12.
Engineering anthracycline biosynthesis toward angucyclines.
The biosynthesis pathways of two anthracyclines, nogalamycin and...
10th September, 2003
Department of Biochemistry, University of Turku, FIN-20014 Turku. Antimicrob Agents Chemother. 2003 Apr;47(4):1291-6.
Studies on a second and third ring cyclization in anthracycline biosynthesis.
This paper focuses on study of second and third ring cyclization in...
28th May, 2003
Galilaeus Oy, P.O. Box 113, FIN-20781, Kaarina, Finland. J Antibiot (Tokyo). 2003 Feb;56(2):143-53.
Hybrid anthracyclines from a genetically engineered Streptomyces galilaeus mutant.
The genetic engineering of antibiotic-producing Streptomyces strains is an...
19th August, 2000
Galilaeus Oy, P.O. Box 113, 20781 Kaarina, Finland, Department of J Org Chem. 2000 May 19;65(10):2851-5.

BioNews Results for Galilaeus Oy:

Ark Therapeutics Group plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new
PR inside:  Nov 16 2009 5:01AM Matching: oy
Encorium Group, Inc. Appoints Sari Laitinen to Board of Directors
KOTA Territory News:  Nov 14 2009 11:05PM Matching: oy
Encorium Group, Inc. Appoints Sari Laitinen to Board of Directors
Montana's News Station:  Nov 14 2009 5:59PM Matching: oy
Encorium Group, Inc. Appoints Sari Laitinen to Board of Directors
KSLA:  Nov 14 2009 7:29AM Matching: oy
Encorium Group, Inc. Appoints Sari Laitinen to Board of Directors
KLFY:  Nov 14 2009 3:55AM Matching: oy
Promote your company here: BioNewsCast - Press Release Distribution

View more Galilaeus Oy news.

Galilaeus Oy Patents:

US Patent No.Title
6399583 Hybrid anthracyclines from genetically engineered streptomyces galilaeus strains, process for production and uses thereof
5986077 Process for producing anthracyclines and intermediates thereof

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 701 times since April 2007, the link to the organisation's website has been followed 53 times

Recent Search Terms used to find this page: galilaeus | .

Search for more companies in KAARINA

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Galilaeus Oy

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.